DATA Waiver Trainings

Providers are required to complete an eight-hour training to qualify for a waiver to prescribe and dispense buprenorphine (Drug Treatment Act of 2000) for 100 or 275 patients. These trainings are certified by the American Society of Addiction Medicine (ASAM) through which physicians are able to obtain the learning requirements necessary to obtain the waiver. These trainings are eight-hour courses (PAs and NPs need an additional 16 hours) that cover treating Opioid Use Disorder using interactive, case-based learning and evidence-based practices. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training.

All DATA Waiver Trainings in 2021 will be moved to a webinar format indefinitely to ensure the safety of our participants. Please check here for further COVID-19 updates

An Introduction to Treating Patients with Buprenorphine

As of April 28th, 2021, the Department of Health and Human Services (HHS) announced that the 8-hour X-waiver buprenorphine course is no longer required to prescribe buprenorphine for the treatment of opioid use disorder for less than 30 patients. Clinicians who apply for and receive a DEA X-license may prescribe buprenorphine for OUD for up to 30 patients without taking the official DATA2000 waiver course. The Introduction to Treating Patients with Buprenorphine course is not a required training,  however, it is for educational purposes for providers who are interested in prescribing for up to 30 patients.

Date: December 10, 2021; 8AM-12PM


Format: Webinar

This webinar will offer CMEs


Buprenorphine for Chronic Pain Management

Date: December 10, 2021; 12-1PM


Format: Webinar

Presenter: Dr. David Cooke

Buprenorphine is not just for addiction!  Learn why it’s a better choice for your patients on chronic opioids for pain, and how to make the switch.

This webinar will offer CMEs and CEUs